DK60990C - Fremgangsmaade til Fremstilling af neutrale eller svagt sure, koncentrerede, vandige Xantinonpløsninger. - Google Patents
Fremgangsmaade til Fremstilling af neutrale eller svagt sure, koncentrerede, vandige Xantinonpløsninger.Info
- Publication number
- DK60990C DK60990C DK60990DA DK60990C DK 60990 C DK60990 C DK 60990C DK 60990D A DK60990D A DK 60990DA DK 60990 C DK60990 C DK 60990C
- Authority
- DK
- Denmark
- Prior art keywords
- xanthinone
- neutral
- concentrated
- aqueous
- solutions
- Prior art date
Links
- QBWXIMRDQPYHAG-UHFFFAOYSA-N 9h-purine-2,6,8-trione Chemical compound O=C1NC(=O)C2=NC(=O)NC2=N1 QBWXIMRDQPYHAG-UHFFFAOYSA-N 0.000 title 1
- 230000002378 acidificating effect Effects 0.000 title 1
- 230000007935 neutral effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/12—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1, 3, and 7, e.g. caffeine
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEC1111D DE892667C (de) | 1940-05-26 | 1940-05-26 | Verfahren zur Herstellung von neutralen bzw. schwach sauren waessrigen Xanthinloesungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK60990C true DK60990C (da) | 1943-06-07 |
Family
ID=7012523
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK60990D DK60990C (da) | 1940-05-26 | 1941-04-02 | Fremgangsmaade til Fremstilling af neutrale eller svagt sure, koncentrerede, vandige Xantinonpløsninger. |
Country Status (2)
| Country | Link |
|---|---|
| DE (1) | DE892667C (da) |
| DK (1) | DK60990C (da) |
-
1940
- 1940-05-26 DE DEC1111D patent/DE892667C/de not_active Expired
-
1941
- 1941-04-02 DK DK60990D patent/DK60990C/da active
Also Published As
| Publication number | Publication date |
|---|---|
| DE892667C (de) | 1953-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK61632C (da) | Fremgangsmaade til Fremstilling af vandige Laktoflavinopløsninger. | |
| DK60990C (da) | Fremgangsmaade til Fremstilling af neutrale eller svagt sure, koncentrerede, vandige Xantinonpløsninger. | |
| DK64936C (da) | Fremgangsmaade til Fremstilling af vejrfaste Landkort, Tegninger eller andre Tryksager. | |
| DK59958C (da) | Fremgangsmaade til Fremstilling af koncentrerede vandige Opløsninger af Dijodtyrosin eller dets Salte. | |
| DK67771C (da) | Fremgangsmåde til Fremstilling af koncentrerede, vandige opløsninger af teofyllin. | |
| DK63112C (da) | Fremgangsmaade til Fremstilling af Benzylimidazolin eller Derivater deraf. | |
| DK59225C (da) | Fremgangsmaade til Fremstilling af alkylerede 2-Dialkyl-6-Oksykromaner. | |
| DK58623C (da) | Fremgangsmaade til Fremstilling af koncentrerede vandige Opløsninger af Dijodtyrosin. | |
| DK59844C (da) | Fremgangsmaade til Fremstilling af sure di-Estere af alkylede 1,4-Naftohydrokinoner. | |
| DK61224C (da) | Fremgangsmaade til Fremstilling af Pyridin-3-eddikesyre eller dens funktionelle Derivater. | |
| DK69526C (da) | Fremgangsmåde til stabilisering af polytionat- eller polytionsyreopløsninger. | |
| DK72128C (da) | Fremgangsmåde til fremstilling af derivater af sulfonamider. | |
| DK76428C (da) | Fremgangsmåde til fremstilling af vandopløselige, metylerede metylol-melaminharpikser. | |
| DK76234C (da) | Fremgangsmåde til fremstilling af sølvsalte af sulfonsyrer. | |
| DK67724C (da) | Fremgangsmåde til fremstilling af vandopløselige 2-alkyl-1,4-naftohydrokinonderivater. | |
| DK57176C (da) | Fremgangsmaade til kontinuerlig Fremstilling af vandige Magniumhypokloritopløsninger. | |
| DK63084C (da) | Fremgangsmaade til Fremstilling af Derivater af 4-Amino-benzolsulfonamid. | |
| DK56297C (da) | Fremgangsmaade til Afgiftning af koffeinholdige Droger eller vandige Edtræk af saadanne. | |
| DK58059C (da) | Fremgangsmaade til Fremstilling af Straamaatter eller Straamaattebaner. | |
| DK67793C (da) | Fremgangsmaade til Fremstilling af 2-Metyl-2,3-dihalogen-tetrahydrofuraner. | |
| DK64127C (da) | Fremgangsmaade til Fremstilling af sure Di-Estere af alkylerede 1,4-Naftohydrokinoner. | |
| DK58481C (da) | Fremgangsmaade til Fremstilling af 2-Metyl-4,6-diokso-5-jod-tetrahydropyridin-1-eddikesyre. | |
| DK59775C (da) | Fremgangsmaade til Fremstilling af α-Oksy-β,β-dimetyl-γ-butyrolakton. | |
| DK58788C (da) | Fremgangsmaade til Fremstilling af viskose sure Rodanidopløsninger. | |
| DK69382C (da) | Fremgangsmåde til fremstilling af i sulfonamidgruppen substituerede derivater af sulfonamider. |